课题基金 / 基金详情

MOLECULAR MECHANISMS OF DIFFERENTIATION IN NEUROBLASTOMA

MOLECULAR MECHANISMS OF DIFFERENTIATION IN NEUROBLASTOMA
神经母细胞瘤分化的分子机制
批准号:
2094085
负责人:
SUSAN L. COHN
金额:
$9.65万
依托单位国家:
美国
项目类别:
财政年份:
1990
资助国家:
美国
项目状态:
已结题
起止时间:
1990-07-01 至 1995-06-30

项目摘要

项目成果

SUSAN L. COHN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Neuroblastoma (NB), a malignant neoplasm of neural crest origin, is the most common extracranial solid tumor in children. Spontaneous differentia- tion of NB to benign ganglioneuroma occurs occasionally in vivo. This process involves the loss of the neuroblast phenotype and the appearance of cells resembling mature ganglionic neurons. Even in NBs which do not mature completely to benign ganglioneuromas, the degree of histologic maturation directly influences the clinical behavior of the tumor and is, therefore, of clinical importance. Because most human neuroblastoma cell lines undergo morphologic and biochemical differentiation in response to a variety of gents including retinoic acid (RA), an excellent in vitro model for the examination of NB differentiation is available. The focus of this study will be to isolate and characterize the genes in NBs in which expression is either induced or down-regulated 180 minutes after treatment with RA by differentially screening a cDNA library constructed from LA-N-5 NB cells treated with RA for 180 minutes with radiolabeled cDNA probes prepared from untreated and RA-treated human NB cells (LA-N-5. By con- centrating on early changes in expression, genes which may be necessary for the implementation of the differentiation process rather than the genes whose products are associated with the specific neural features of the differentiated cell may be isolated. Other NB cell lines, many of which have been established an characterized in this laboratory, will subsequent- ly be probed with the differentiation related sequences to determine if these clones are expressed after RA treatment in other N-myc amplified and unamplified lines. In addition, the expression of these genes in primary tumors and the relationship between the levels of expression and the degree of histologic differentiation, and clinical outcome will be determined. Finally, these sequences will be incorporated into expression vectors and introduced back into human NB cells. Biological effects of the expressed clones in recipient cells will then be analyzed. Understanding the molecular mechanisms of NB differentiation may provide insight into the altered regulation of differentiation associated with NB.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
Evidence for molecular heterogeneity in human ganglioneuroblastoma.
人类神经节神经母细胞瘤分子异质性的证据。
DOI: 10.3109/15513819309048265
发表时间: 1993
期刊: Pediatric pathology
影响因子: --
作者: [Schmidt,ML, Salwen,HR, Chagnovich,D, Bauer,KD, Crawford,SE, Cohn,SL]
通讯作者: Cohn,SL
DOI: --
发表时间: 1993-07
期刊: Biochemistry and molecular biology international
影响因子: --
作者: [C. Manohar;M. Furtado;H. Salwen;S. Cohn]
通讯作者: C. Manohar;M. Furtado;H. Salwen;S. Cohn
Lack of correlation of N-myc gene amplification with prognosis in localized neuroblastoma: a Pediatric Oncology Group study.
N-myc 基因扩增与局限性神经母细胞瘤预后缺乏相关性:一项儿科肿瘤小组研究。
DOI: --
发表时间: 1995
期刊: Cancer research.
影响因子: --
作者: [Cohn,SL, Look,AT, Joshi,VV, Holbrook,T, Salwen,H, Chagnovich,D, Chesler,L, Rowe,ST, Valentine,MB, Komuro,H]
通讯作者: Komuro,H
DOI: --
发表时间: 1994-02
期刊: Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research
影响因子: --
作者: [Mary Lou Schmidt;H. Salwen;C. Manohar;N. Ikegaki;Susan L. Cohn]
通讯作者: Mary Lou Schmidt;H. Salwen;C. Manohar;N. Ikegaki;Susan L. Cohn
ITM 2.0: Advancing Translational Science in Metropolitan Chicago
  • 批准号:
    9528017
  • 项目类别:
  • 资助金额:
    $583.76万
  • 财政年份:
    2017
  • 负责人:
    SUSAN L. COHN
  • 依托单位:
Mechanisms of Pancreatic Cancer Inhibition by SPARC
  • 批准号:
    8584190
  • 项目类别:
  • 资助金额:
    $20.62万
  • 财政年份:
    2013
  • 负责人:
    SUSAN L. COHN
  • 依托单位:
Mechanisms of Pancreatic Cancer Inhibition by SPARC
  • 批准号:
    8692697
  • 项目类别:
  • 资助金额:
    $16.67万
  • 财政年份:
    2013
  • 负责人:
    SUSAN L. COHN
  • 依托单位:
Mechanism of SPARC peptide FSEC inhibition of angiogenesis in neuroblastoma
  • 批准号:
    8512433
  • 项目类别:
  • 资助金额:
    $23.7万
  • 财政年份:
    2013
  • 负责人:
    SUSAN L. COHN
  • 依托单位:
海外基金